How I treat pain in hematologic malignancies safely with opioid therapy.
Ontology highlight
ABSTRACT: The field of malignant hematology has experienced extraordinary advancements with survival rates doubling for many disorders. As a result, many life-threatening conditions have since evolved into chronic medical ailments. Paralleling these advancements have been increasing rates of complex hematologic pain syndromes, present in up to 60% of patients with malignancy who are receiving active treatment and up to 33% of patients during survivorship. Opioids remain the practice cornerstone to managing malignancy-associated pain. Prevention and management of opioid-related complications have received significant national attention over the past decade, and emerging data suggest that patients with cancer are at equal if not higher risk of opioid-related complications when compared with patients w
SUBMITTER: Geyer HL
PROVIDER: S-EPMC8765122 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA